Chicago Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Chicago Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-666,000	Closed	-$7.23M	–	33
2026 Q1	$7.23M	Buy	666,000 +266,000	+67%	+$3.81M	5.99%	5
2025 Q4	$4.28M	Buy	+400,000	New	+$3.93M	2.92%	17

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Chicago Capital Management's FOLD Position: Q2 2026 in Review

Chicago Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 666,000 shares — an estimated $7.23M sold.

Chicago Capital Management first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $7.23M in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

Chicago Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Chicago Capital Management sold 666,000 Amicus Therapeutics shares in Q2 2026, an estimated $7.23M.
Chicago Capital Management first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Chicago Capital Management's Amicus Therapeutics position peaked at $7.23M in Q1 2026.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Chicago Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.